This time from former NSF Director Neil Lane and CU Professor Roger Pielke, in Nature here. Hat tip to Phil R.
I’m really pleased by the results released this morning for the Pfizer vaccine candidate. It feels like a tipping point for this fight and a welcome development for the incoming Biden Administration.
I was reading the paper when I heard the news. It’s a magnificent Fall day here in DC. In the hour or so afterwards, we saw children waving American Flags in the Palisades neighborhood as cars honked and folks cheered. On my phone, the video of New York City erupting in spontaneous joy. A colleague texted about the prospect of four years freed from the negative headspace of her twitter feed–able to focus on science instead of fear.
Having worked on the Cancer Moonshot during the Obama Administration and personally witnessed the leadership of our new President-elect, I am optimistic. We used our vote to chose well.
First, I subscribe to Tolstoy’s view of history rather than Carlyle’s “Great Man” viewpoint. So, from my point of view, where the US find’s itself in this particular election is not so much a function of the person currently holding the office, but more of where the US polity is right now.
Second, the problem of humanity’s position with regards to the rest of the biosphere aren’t going to really change after Tuesday. Whoever wins, the climate disruption will continue and the follow-on effects, both predicted and unknown, will continue to challenge us.
Third, much goes on outside the borders of the United States: some good, some bad, but all of interest in any case. I am intrigued by the entire notion of the Pacific Rim as a geo-political entity. Mostly, it seems to have a dynamism that the rest of the geopolitical world lacks these days.
Finally, the US continues to be beautiful–the land itself is the greatest asset of this place that I call home.
I hope. Here’s one running for US Senator in Wyoming, Merav Ben-David. Anytime I see scientists entering the political arena I want to cheer them on. Our profession needs to become far more active in setting an agenda for the future. And that can’t be done entirely outside of politics. She’s running as a Dem. Now let’s see a scientist step up from the other side of the aisle. Oh wait, here’s one with an impeccable NSF record. Kelvin?
I don’t find myself often agreeing with David Brooks, but today’s column in the NYT was excellent. There is certainly a lot to fix and it’ll definitely be “the work of a generation”.
I’ve been following the Artemis Accords closely. They represent a follow-on to the Outer Space Treaty of 1967 and the immediate context is the US goal of returning humans to the Moon by 2024. I’m less interested in the return trip to the Moon than I am in future legal frameworks for Space.
With regards to such legal frameworks:
To my mind there is the question of extraction of valuable resources from the Solar System and the property rights that might accompany those. Then there is the question of how, in the future, the notion of Westphalian nation states might extend off the planet. An additional question is about the militarization of space by current nations although it looks to me that the horse has already left the barn on that one.
N.B. As a matter of record, I’m inclined to oppose the notion of a separate US Space Force because I think such a DOD organization will push us further down the road of deploying offensive weapons on orbit–a bad thing, in my opinion.
- What shapes toxin evolution towards signal transduction nodes and edges
- Next generation gas flux measurements beyond eddy covariance
- Angiotensin Converting Enzyme II
- Why plants lost protein kinase C and changed other aspects of phospholipid signaling
- How software designed radio could empower environmental sensor networks
- Planetary hysteresis mechanisms on Earth and Mars
- The origins of cellular electrical excitability
- How the ribosome came to be
Fantastic news this morning as the Nobel Prize in Chemistry was awarded to Jennifer Doudna and Emmanuelle Charpentier for CRISPR gene editing. Story here. I’m proud that NSF’s Biological Sciences Directorate played an important role in supporting Dr. Doudna’s research through the Division of Molecular and Cellular Biology. Kudos to the winners and their funders.